SCHEMBL422409

SCHEMBL422409

NC(=O)N(c1ccc(-c2cccc3onc(N)c23)cc1)c1cccc(Cl)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 16/20 0.61
KIT P10721 15/20 0.61
FLT3 P36888 13/20 0.61
MET P08581 4/20 0.52
SRC P12931 2/20 0.48
LCK P06239 2/20 0.48
CSF1R P07333 2/20 0.48
LYN P07948 2/20 0.48
FLT1 P17948 2/20 0.48
FLT4 P35916 2/20 0.48
BLK P51451 2/20 0.48
ABL1 P00519 1/20 0.48
FYN P06241 1/20 0.48
ROCK2 O75116 2/20 0.48
RPS6KA5 O75582 2/20 0.48
RET P07949 2/20 0.48
FGFR1 P11362 2/20 0.48
RPS6KB1 P23443 2/20 0.48
FRK P42685 2/20 0.48
RPS6KA3 P51812 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5301508 0.89 KDR (0.62) KDRKITFLT3METSRC
SCHEMBL27657321 0.89 KIT (0.65) KDRKITFLT3METLCK
SCHEMBL28757596 0.87 KDR (0.60) KDRKITFLT3METSRC
SCHEMBL27636423 0.87 KDR (0.60) KDRKITFLT3METSRC
SCHEMBL6800761 0.87 KDR (0.60) KDRKITFLT3METSRC
SCHEMBL5306697 0.87 KDR (0.65) KDRKITFLT3METSRC
SCHEMBL27636359 0.86 KDR (0.51) KDRKITFLT3METSRC
SCHEMBL28757593 0.85 KDR (0.53) KDRKITFLT3METSRC
SCHEMBL5311742 0.85 KDR (0.52) KDRKITFLT3METSRC
SCHEMBL27791459 0.85 KDR (0.62) KDRKITFLT3METSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1826324-A Indazole, benzisoxazole and benzisothiazole kinase inhibitors ABBOTT LAB (US) 2006-08-30 CN claimed
US-8299243-B2 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors ABBVIE INC. (US) 2012-10-30 US disclosed
US-20120022253-A1 INDAZOLE, BENZISOXAZOLE, AND BENZISOTHIAZOLE KINASE INHIBITORS ABBOTT LABORATORIES (US) 2012-01-26 US disclosed
CN-101827584-A Solid dispersion product of N-aryl ureido drugs ABBOTT GMBH & CO KG 2010-09-08 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022253-A1 INDAZOLE, BENZISOXAZOLE, AND BENZISOTHIAZOLE KINASE INHIBITORS ABL1, BLK, BTK KDR 724/4885KIT 361/4885FLT3 41/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.